Médecins Sans Frontières-Operational Center Barcelona-Athens, Barcelona, Spain.
Trop Med Int Health. 2012 May;17(5):666-73. doi: 10.1111/j.1365-3156.2012.02960.x. Epub 2012 Mar 5.
Bihar, the poorest state in India, concentrates most of the visceral leishmaniasis (VL) cases in the country. A large proportion of the poor rural communities where VL is endemic are marginalized by their socio-economic status, intrinsically related to the caste system. In this study, we evaluated whether people from low socio-economic strata had difficulties accessing VL treatment in Bihar. As a secondary outcome, we evaluated whether people delaying their VL treatment had poorer clinical indicators at admission.
Data on 2187 patients with VL treated by Médecins Sans Frontières (MSF) in Vaishali district from July 2007 to December 2008 were analysed. Patients who reported having onset of symptoms ≥8 weeks before admission were defined as 'late presenters'. Logistic regression models were used to evaluate whether low castes had higher risk to be 'late presenters' compared to the rest of castes and whether 'late presenters' had poorer indicators at admission (i.e. haemoglobin level, spleen size).
After adjusting for age, gender and distance to VL treatment facility, Mushars (the lowest caste in Bihar) had twice the odds to be 'late presenters' compared to the rest of castes (OR 2.05, 95% CI: 1.24-2.38). Subjects that had VL symptoms for ≥8 weeks had a larger spleen and lower haemoglobin level than those that were treated earlier.
Low castes have poor access to VL treatment in Bihar, and late presenters have poorer clinical indicators at admission. These findings have implications at individual and community levels and should stimulate targeted VL control programmes to ensure that marginalized communities in Bihar are properly treated.
印度最贫穷的比哈尔邦集中了该国大部分内脏利什曼病(VL)病例。在 VL 流行的大部分贫困农村社区中,由于其社会经济地位较低,与种姓制度密切相关,这些社区处于被边缘化的境地。在这项研究中,我们评估了社会经济地位较低的人在比哈尔邦是否难以获得 VL 治疗。作为次要结果,我们评估了是否延迟 VL 治疗的人在入院时具有较差的临床指标。
分析了 2007 年 7 月至 2008 年 12 月在 Vaishali 区由无国界医生组织(MSF)治疗的 2187 名 VL 患者的数据。将报告症状出现≥8 周前入院的患者定义为“晚期患者”。使用逻辑回归模型评估低种姓与其他种姓相比,是否具有更高的风险成为“晚期患者”,以及“晚期患者”在入院时是否具有较差的指标(即血红蛋白水平,脾脏大小)。
在调整年龄,性别和距离 VL 治疗设施后,Mushars(比哈尔邦的最低种姓)成为“晚期患者”的几率是其他种姓的两倍(OR 2.05,95%CI:1.24-2.38)。VL 症状持续≥8 周的患者的脾脏较大,血红蛋白水平较低,而早期治疗的患者则相反。
在比哈尔邦,低种姓人群获得 VL 治疗的机会较差,晚期患者入院时的临床指标较差。这些发现对个人和社区层面都具有影响,应刺激有针对性的 VL 控制计划,以确保比哈尔邦的边缘化社区得到妥善治疗。